2 weeks Ago By Defense World Staff
Brown Shipley& Co Ltd lessened its position in shares of Colgate-Palmolive ( NYSE:CL – Free Report ) by 39.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 600 shares of the company’s stock after selling 388 shares during the period.
Brown Shipley& Co Ltd’s holdings in Colgate-Palmolive were worth $58,000 at the end of the most recent reporting period. Several other institutional investors and hedge funds also recently made changes to their positions in CL. B.
Riley Wealth Advisors Inc. boosted its position in Colgate-Palmolive by 7.3% during the second quarter.
B. Riley Wealth Advisors Inc. now owns 17,851 shares of the company’s stock worth $1,732,000 after purchasing an additional 1,212 shares during the period.
Wallace Capital Management Inc. raised its holdings in Colgate-Palmolive by 1.1% during the 2nd quarter.
Wallace Capital Management Inc. now owns 13,290 shares of the company’s stock valued at $1,290,000 after acquiring an additional 150 shares during the period. Second Line Capital LLC lifted its position in shares of Colgate-Palmolive by 36.
7% during the second quarter. Second Line Capital LLC now owns 3,352 shares of the company’s stock worth $325,000 after acquiring an additional 900 shares in the last quarter. NewEdge Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 11.
7% in the second quarter. NewEdge Advisors LLC now owns 51,375 shares of the company’s stock worth $4,985,000 after acquiring an additional 5,363 shares during the period. Finally, Silver Lake Advisory LLC grew its position in shares of Colgate-Palmolive by 7.
4% in the second quarter. Silver Lake Advisory LLC now owns 6,707 shares of the company’s stock valued at $651,000 after purchasing an additional 464 shares in the last quarter. Institutional investors own 80.
41% of the company’s stock. Insider Transactions at Colgate-Palmolive In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.
94, for a total value of $1,522,894.36. Following the transaction, the insider now owns 5,146 shares in the company, valued at $529,729.
24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink . In other Colgate-Palmolive news, EVP Gregory Malcolm sold 10,533 shares of the firm’s stock in a transaction dated Tuesday, August 6th.
The shares were sold at an average price of $103.10, for a total value of $1,085,952.30.
Following the completion of the sale, the executive vice president now directly owns 10,377 shares in the company, valued at $1,069,868.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link .
Also, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.
36. Following the completion of the sale, the insider now directly owns 5,146 shares in the company, valued at $529,729.24.
The disclosure for this sale can be found here . Over the last 90 days, insiders have sold 43,490 shares of company stock worth $4,486,063. Insiders own 0.
34% of the company’s stock. Wall Street Analyst Weigh In Check Out Our Latest Report on CL Colgate-Palmolive Price Performance CL stock opened at $103.66 on Monday.
The firm has a market cap of $85.05 billion, a P/E ratio of 32.80, a P/E/G ratio of 3.
62 and a beta of 0.40. The firm’s fifty day moving average is $103.
25 and its 200 day moving average is $96.42. Colgate-Palmolive has a 52 week low of $67.
62 and a 52 week high of $109.30. The company has a debt-to-equity ratio of 16.
90, a quick ratio of 0.70 and a current ratio of 1.06.
Colgate-Palmolive ( NYSE:CL – Get Free Report ) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.
87 by $0.04. Colgate-Palmolive had a return on equity of 470.
19% and a net margin of 14.21%. The firm had revenue of $5.
06 billion for the quarter, compared to analysts’ expectations of $5 billion. During the same period last year, the firm earned $0.77 earnings per share.
The company’s revenue for the quarter was up 4.9% compared to the same quarter last year. Research analysts predict that Colgate-Palmolive will post 3.
57 earnings per share for the current year. Colgate-Palmolive Dividend Announcement The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.
50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.
93%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.
29%. About Colgate-Palmolive ( Free Report ) Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition.
The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. Featured Stories Five stocks we like better than Colgate-Palmolive What is a Secondary Public Offering? What Investors Need to Know 3 Bargain Stocks Under $20 With Major Growth Potential What is a SEC Filing? Top 5 ETFs to Own Now and Into 2025 How to Evaluate a Stock Before Buying Watch These 3 Former Short-Squeeze Stocks for a Big Rally Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive ( NYSE:CL – Free Report ).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter ..
